{"id":951,"date":"2021-03-16T17:30:03","date_gmt":"2021-03-16T20:30:03","guid":{"rendered":"https:\/\/www.vitapharmaconsulting.com\/en\/?post_type=noticias&p=951"},"modified":"2022-04-28T15:36:14","modified_gmt":"2022-04-28T18:36:14","slug":"whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations","status":"publish","type":"noticias","link":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/","title":{"rendered":"Whitepaper: Medicinal Cannabis Products – Regulatory differences between Brazilian and Mexican Legislations"},"content":{"rendered":"

We have published our new Whitepaper that describes the main differences between Mexican and Brazilian legislations regarding the Sanitary Authorization for Medicinal Cannabis Products.
\nThe document presents a brief description of the legislations in each country and brings a comparative about the regulated activities, such as: authorization for cultivation, import\/export, prescription, dispensation, among others.<\/p>\n

But after all, what is a whitepaper?<\/p>\n

It is nothing more than a material with more in-depth content on a given subject. Warning: it is not a scientific article.<\/p>\n

We have prepared this document by consulting the legislation of each country, and through the searching for information available at the page of the Regulatory Agencies, in order to identify the main points of similarity and difference between regulations.<\/p>\n

If you are already a subscriber to the Vita\u2019s Newsletter, you must have already received the document. If it is not yet, and if you want to have access to the whitepaper, just request it using the form below, thus subscribing to our newsletter, and the file will be immediately available for download.
\nSee you soon!<\/p>\n","protected":false},"author":1,"featured_media":952,"template":"","meta":{"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categorias":[22,23],"yoast_head":"\nWhitepaper: Medicinal Cannabis Products - Regulatory differences between Brazilian and Mexican Legislations - Vita<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Whitepaper: Medicinal Cannabis Products - Regulatory differences between Brazilian and Mexican Legislations - Vita\" \/>\n<meta property=\"og:description\" content=\"We have published our new Whitepaper that describes the main differences between Mexican and Brazilian legislations regarding the Sanitary Authorization for Medicinal Cannabis Products. The document presents a brief description of the legislations in each country and brings a comparative about the regulated activities, such as: authorization for cultivation, import\/export, prescription, dispensation, among others. But... Leia mais »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-28T18:36:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2022\/04\/IMAGEM-128.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/\",\"name\":\"Whitepaper: Medicinal Cannabis Products - Regulatory differences between Brazilian and Mexican Legislations - Vita\",\"isPartOf\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\"},\"datePublished\":\"2021-03-16T20:30:03+00:00\",\"dateModified\":\"2022-04-28T18:36:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Whitepaper: Medicinal Cannabis Products – Regulatory differences between Brazilian and Mexican Legislations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/\",\"name\":\"Vita\",\"description\":\"Regulatory affairs & consulting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Whitepaper: Medicinal Cannabis Products - Regulatory differences between Brazilian and Mexican Legislations - Vita","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/","og_locale":"pt_BR","og_type":"article","og_title":"Whitepaper: Medicinal Cannabis Products - Regulatory differences between Brazilian and Mexican Legislations - Vita","og_description":"We have published our new Whitepaper that describes the main differences between Mexican and Brazilian legislations regarding the Sanitary Authorization for Medicinal Cannabis Products. The document presents a brief description of the legislations in each country and brings a comparative about the regulated activities, such as: authorization for cultivation, import\/export, prescription, dispensation, among others. But... Leia mais »","og_url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/","og_site_name":"Vita","article_modified_time":"2022-04-28T18:36:14+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2022\/04\/IMAGEM-128.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/","url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/","name":"Whitepaper: Medicinal Cannabis Products - Regulatory differences between Brazilian and Mexican Legislations - Vita","isPartOf":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website"},"datePublished":"2021-03-16T20:30:03+00:00","dateModified":"2022-04-28T18:36:14+00:00","breadcrumb":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/03\/16\/whitepaper-medicinal-cannabis-products-regulatory-differences-between-brazilian-and-mexican-legislations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/"},{"@type":"ListItem","position":2,"name":"Whitepaper: Medicinal Cannabis Products – Regulatory differences between Brazilian and Mexican Legislations"}]},{"@type":"WebSite","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website","url":"https:\/\/www.vitapharmaconsulting.com\/en\/","name":"Vita","description":"Regulatory affairs & consulting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias\/951"}],"collection":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media\/952"}],"wp:attachment":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=951"}],"wp:term":[{"taxonomy":"categorias","embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/categorias?post=951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}